A new research paper was published in Oncotarget, Volume 16, on February 18, 2025, titled “Robust p53 phenotypes and ...

Cancer arises when your cells grow uncontrollably and refuse to die when they should. Normally, your body is equipped with ...

A new research paper was published in , Volume 16, on February 18, 2025, titled "Robust p53 phenotypes and prospective downstream targets in telomerase-immortalized human cells." ...

The Philippine Economic Zone Authority (Peza) has approved P52.93 billion worth of investment pledges in the first two months ...

p53 is a common denominator among human cancers. How was it discovered? What are the persistent questions about its function? Aa Aa Aa It seems nearly impossible for a normal cell to become a ...

Clinical research suggests that combining a novel agent called navtemadlin with DNA-damaging chemotherapy for the treatment of glioblastoma, a form of brain cancer, could increase efficacy.

Characterizing the clinical and genomic features of androgen indifferent prostate cancer. Distribution of manual p53 scores (rows) and automated digital image analysis (DIA) p53 scores (columns) by ...

Investigation of the association of CTRB2 exon 6 deletion with time to progression and overall survival in pancreatic ductal adenocarcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

The Philippine Economic Zone Authority (PEZA) has approved PHP52.93 billion worth of investment pledges in the first two ...